Summary.-There is now evidence that several classes of nitro compounds which have been used as radiosensitizers also function as cytotoxic agents specific for hypoxic cells. The 2-nitroimidazole, Ro-07-0582, (1-(2-nitroimidazol-1-yl)-3-methoxy-2-propanol) is a compound of this type, and its effectiveness as a cytotoxic agent is dependent on drug concentration, contact time and temperature. In vitro, Ro-07-0582 in air at 37°C does not cause loss of cell viability at concentrations up to 2 mM, even when in contact for several days. In contrast, hypoxic cells do not tolerate much lower concentrations of drug, even if the contact time is only a few hours. When the temperature is raised above 37°C, there is a pronounced increase in the slope of the survival curves; for example, at 41°C (for 1 mM Ro-07-0582, (200 ,ug/ml), the slope changes by a factor of 2-0 relative to that for 37°C. For cells in air at 41°C, as at 37°C, there is no toxic effect at the concentration of drug tested. In the absence of drug, there is no cytotoxic effect of hyperthermia alone under these conditions. These results are discussed in terms of Arrhenius parameters.
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THE relative radioresistance of hypoxic cells believed to be present in some human tumours is a likely cause of local failure in radiotherapy. Methods suggested to overcome the problem include the use of hypoxic cell radiosensitizers (Adams, 1973) (Urtasun et al., 1975 (Urtasun et al., , 1976 Gray et al., 1976; Dische, Gray and Zanelli, 1976; Thomlinson et al., 1976 ). An interesting recent finding is that both these drugs display a marked differential cytotoxicity towards hypoxic relative to well-oxygenated cells (Sutherland, 1974; Hall and Roizin-Towle, 1975; Foster et al., 1976; Mohindra and Rauth, 1976) , and this has led to consideration of their possible future role in cancer chemotherapy in addition to their use as radiosensitizers. During investigations into the mechanism of this effect, we have found that moderate hyperthermia pro- These results for aerobic cells contrast markedly with those for hypoxic cells maintained in contact with Ro-07-0582. Fig. 2 shows plots of surviving fraction against time in hours for hypoxic suspensions containing 0 5, 1P0 and 2 0 mM Ro-07-0582. In the drug-free control, there is no loss of viability during the course of the experiments. With drug present, there is an initial shoulder, after which cell survival decreases exponentially with time. (Sutherland, 1974; Hall and Roizin-Towle, 1975; Foster et al., 1976; Mohindra and Rauth, 1976 The dashed lines in Fig. 3D are the survival data for 37°C, transposed from Fig. 2 for comparison. The arrows in the figure indicate the considerable increase in cytotoxicity caused by a rise in temperature of only 40C for the three Ro-07-0582 concentrations indicated. Generally as the temperature is increased, the rate of cell killing, as measured by the slope of the exponential portion of the survival curves, increases. Also, the increase in temperature, certainly at concentrations of 2 mm Ro-07-0582 and above, greatly reduces the shoulder on the survival curves.
The hypoxic cell toxicity of Ro-07-0582 is clearly dependent upon temperature, drug concentration and overall contact time. This is illustrated by the isoeffect curves shown in Fig. 4 . The data indicate the contact time required for reduction of cell survival by a factor of 10-3, plotted as a function of Ro-07-0582 concentration for the 4 different temperatures. As the temperature increases, the concentrations of drug and the contact time necessary to reach a given level of survival both decrease.
(c) Analysis of temperature dependence in terms of Arrhenius parameters It is assumed that the toxicity is due to the reaction either of the sensitizer, or of some metabolic breakdown product of the senitizer, with critical target molecules, or sites within the cell. If this reaction leads directly to loss of cell viability, then it should be possible to derive the activation energy for the reaction.
Let the effective concentration of critical targets at time t after contact with the sensitizer be x, and let S be the initial concentration of the sensitizer. Then
where k is a reaction constant. Since the concentration of S available in the medium is unchanged throughout the inactivation dx If the toxicity were due simply to the reaction of Ro-07-0582 itself with a critical target site within the cell, one might expect that the temperature coefficient for the reaction would be constant, both in the hypo-and hyperthermia range. The breakpoint in Fig. 5 is suggestive, therefore, that the toxicity is a consequence of the cellular metabolismn of Ro-07-0582, and that in the hyperthermia range the increased metabolism is responsible for that enhanced temperature coefficient. Spectrophotometric analysis of aqueous solutions of Ro-07-0582 shows that the stability of this drug is unaffected by maintaining the temperature at 41°C for up to 8 h.
Differential hypoxic cell toxicity is evident for numerous other nitro-heterocyclic and nitrobenzenoid drugs (Stratford, Watts and Adams, unpub.) . Further, these compounds become more toxic to hypoxic cells as the electron affinity increases (Adams et al., unpub.) , although the molecular mechanism of the effect remains unclear.
It has been proposed that the cytotoxic action of some nitro compounds, including nitroimidazoles, against anaerobic bacteria is due to the formation of toxic products by reduction of the NO2 group (McCalla, Reuvers and Kaiser, 1970; Ings,. McFadzean and Ormerod, 1974) . For Ro-07-0582, a reduced product, believed to be the corresponding amine, has been identified following incubation of hypoxic cultures of CHO cells with the drug (Varghese, Gulyas and Mohindra, 1976 . It would be inferred from the in vitro data at 370C, that tumours in contact with drug concentrations of this order for several hours would undergo an appreciable reduction in hypoxic cell content. Further, it would follow that, if the tumour temperature could be increased by 4C0 over a period of some hours, the number of hypoxic cells could be even further reduced by the increased cytotoxic action of Ro-07-0582.
Studies on the combined effect of hyperthermia and Ro-07-0582 on mouse tumours (Bleehen, Honess and Morgan, 1977; George, Hirst and McNally, 1977) , have demonstrated that thermal enhancement of the cytotoxic action of this nitroimidazole does occur in vivo.
Cytotoxic drugs of this type may have a role to play in cancer chemotherapy generally, in addition to their more specific use as hypoxic cell radiosensitizers. If so, the present results indicate that the efficiency of combinations of radiation and chemotherapy using Ro-07-0582 or related drugs may be significantly increased by the additional use of modest hyperthermia.
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